中新网北京3月3日电(记者赵方园)一度被冠以“烧钱一哥”的A股创新药龙头百济神州,终于在2025年迎来了历史性转折。 近期,百济神州发布2025年度业绩快报,报告期内实现营业总收入382.05亿元,同比增长40.4%;归属于上市公司股东的净利润14.22亿元。而在2024年同期,公司亏损49.78亿元。 这是百济神州成立十六年以来首次实现全年盈利。 然而,在业绩快报发布前后,其港股、A股及...
Source Link中新网北京3月3日电(记者赵方园)一度被冠以“烧钱一哥”的A股创新药龙头百济神州,终于在2025年迎来了历史性转折。 近期,百济神州发布2025年度业绩快报,报告期内实现营业总收入382.05亿元,同比增长40.4%;归属于上市公司股东的净利润14.22亿元。而在2024年同期,公司亏损49.78亿元。 这是百济神州成立十六年以来首次实现全年盈利。 然而,在业绩快报发布前后,其港股、A股及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.